M 1215 Pill - yellow round, 10mm
Pill with imprint M 1215 is Yellow, Round and has been identified as Levofloxacin 250 mg. It is supplied by Mylan Pharmaceuticals Inc.
Levofloxacin is used in the treatment of Bacterial Infection; Bladder Infection; Anthrax; Anthrax Prophylaxis; Plague Prophylaxis and belongs to the drug class quinolones and fluoroquinolones. Risk cannot be ruled out during pregnancy. Levofloxacin 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M 1215
Levofloxacin
- Imprint
- M 1215
- Strength
- 250 mg
- Color
- Yellow
- Size
- 10.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Quinolones and fluoroquinolones
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-1215 (Discontinued)
- Inactive Ingredients
-
lactose anhydrous,
silicon dioxide,
croscarmellose sodium,
D&C Yellow No. 10,
FD&C Blue No. 2,
FD&C Yellow No. 6,
hypromelloses,
magnesium stearate,
microcrystalline cellulose,
polyethylene glycol,
polydextrose,
povidone,
corn starch,
sodium lauryl sulfate,
titanium dioxide,
triacetin
Note: Inactive ingredients may vary.
Related images for "M 1215"
More about levofloxacin
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (740)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: quinolones and fluoroquinolones
- Breastfeeding
Patient resources
- Levofloxacin drug information
- Levofloxacin injection
- Levofloxacin (Intravenous) (Advanced Reading)
- Levofloxacin (Oral) (Advanced Reading)
- Levofloxacin Tablets
- Levofloxacin Oral Solution
Other brands
Professional resources
- Levofloxacin monograph
- Levofloxacin (FDA)
- Levofloxacin Injection Concentrate (FDA)
- Levofloxacin Oral Solution (FDA)
- Levofloxacin Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
